Cardiovascular determinants of the 6-minute walk distance in cardiac transthyretin amyloidosis
{{output}}
Background: The six-minute walk distance (6MWD) is a measure of functional capacity and a frequently used endpoint in clinical trials investigating transthyretin amyloid cardiomyopathy (ATTR-CM). We evaluated the clinical utility... ...
